Cell therapy for muscular dystrophies
The group focuses on developing cell-based therapies with both donor and autologous, genetically corrected, stem/progenitor cells for musclar dystrophies. In addition work is carried out on mesoderm progenitor lineage choices during the fetal and postnatal stages of development.
Keywords
Skeletal myogenesis / pericytes / mesoderm stem cells / muscle cell therapy / tissue engineering